Novel thrombosis risk index as predictor of left ventricular assist device thrombosis

ASAIO Journal

Volumn 59, Issue 4, 2013, Pages 380-383

  Trivedi, Jaimin R ^a   Sobieski, Michael A ^a   Schwartz, Samuel ^a   Williams, Matthew L ^a   Slaughter, Mark S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

left ventricular assist device; LVAD; thrombosis

Indexed keywords

BLOOD VESSELS; DISEASES; FIBER OPTIC SENSORS; PATIENT TREATMENT;

BLEEDINGS; BRAIN NATRIURETIC PEPTIDE; EFFECTIVE THERAPY; HEART FAILURE; INTERNATIONAL NORMALIZED RATIOS; LACTATE DEHYDROGENASE; PATIENT SURVIVALS; QUALITY OF LIFE; RISK INDICES; THROMBOSE;

LEFT VENTRICULAR ASSIST DEVICES;

BRAIN NATRIURETIC PEPTIDE; D DIMER; FIBRINOGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; FEMALE; HEMODYNAMICS; HUMAN; IMPLANTATION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS;

EID: 84881055357     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318291d0c1     Document Type: Article

References (10)

1. Ezekowitz JA, Lee DS, Tu JV, Newman AM, McAlister FA: Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%. Am J Cardiol 102: 79-83, 2008.
2. Miller LW, Pagani FD, Russell SD, et al; HeartMate II Clinical Investigators: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896, 2007.
3. Rogers JG, Aaronson KD, Boyle AJ, et al; HeartMate II Investigators: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55: 1826-1834, 2010.
4. Griffith BP, Kormos RL, Borovetz HS, et al: HeartMate II left ventricular assist system: From concept to first clinical use. Ann Thorac Surg 71(3 suppl): S116-S120; discussion S114, 2001.
5. Boyle AJ, Russell SD, Teuteberg JJ, et al: Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation. J Heart Lung Transplant 28: 881-887, 2009.
6. Slaughter MS, Sobieski MA, Gallagher C, Graham J, Brandise J, Stein R: Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device. ASAIO J 54: 115-119, 2008.
7. John R, Panch S, Hrabe J, et al: Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg 88: 1171-1179, 2009.
8. John R, Kamdar F, Liao K, et al: Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 136: 1318-1323, 2008.
9. Jourdain P, Jondeau G, Funck F, et al: Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol 49: 1733-1739, 2007.
10. Sareyyupoglu B, Boilson BA, Durham LA, et al: B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J 56: 527-531, 2010.